Hearing Loss, Sensorineural: Clinical Trials

461 trials for Hearing Loss, Sensorineural, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

219 completed, 77 recruiting, 66 unknown, 29 not yet recruiting. 251 Not applicable, 49 Phase 2, 31 Phase 1, 17 Phase 3, 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable251Completed 135, Recruiting 39, Unknown 32, Not yet recruiting 14, Active not recruiting 9, Enrolling by invitation 8, Terminated 7, Withdrawn 7
Phase 249Completed 18, Recruiting 9, Terminated 7, Active not recruiting 4, Unknown 4, Withdrawn 4, Not yet recruiting 2, Suspended 1
Phase 131Completed 15, Recruiting 6, Unknown 3, Terminated 2, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 317Terminated 6, Completed 3, Unknown 3, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Early Phase 17Completed 3, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 41Withdrawn 1

Follow Hearing Loss, Sensorineural: new trials by email Literature Review of Hearing Loss, Sensorineural trials Research Report on Hearing Loss, Sensorineural

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
Otic neural progenitors, cochlear implantation - Sensorineural Hearing Loss, Presbyacusis
Phase 1 / Phase 2Not yet recruitingRinri Therapeutics202027-09-012026-10-01
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
The Microtable® Stereotactic System - Hearing Loss, Cochlear
Not applicableNot yet recruitingMedical University of South Carolina122027-07-012026-06-18
Intervention for Hearing Health Among Native Americans
Talking Circle, Diabetes prevention program & delayed TC - Noise-Induced Hearing Loss
Not applicableNot yet recruitingUniversity of California, San Francisco4002027-04-012026-08-21
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
Dexamethasone, Hyaluronic acid, Indocyanine green(ICG) - Hearing Loss, Sensorineural, Hearing Loss, Sudden
Phase 1 / Phase 2WithdrawnSeoul National University Hospital2026-12-152026-05-22
24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3Not yet recruitingNacuity Pharmaceuticals, Inc.802026-12-012026-07-01
HEARS Maryland: Extending Capacity for Affordable, Accessible Hearing Care Through Older Adult Peer Mentorship
HEARS MD Device, HEARS MD Program - Hearing Loss, Hearing Impairment
Not applicableNot yet recruitingJohns Hopkins University3002026-11-302026-07-29
Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
No intervention, will not receive any active study intervention, Intravitreal Injection of Ultevursen - Retinitis Pigmentosa (RP), Usher Syndrome Type 2
Phase 2Not yet recruitingLaboratoires Thea812026-10-052026-09-01
A Multilevel Intervention to Prevent Noise Exposure in Farmworkers
Multilevel Hearing Protection Training - Noise Exposure, Hearing Loss, Noise-Induced
Not applicableNot yet recruitingSan Diego State University2002026-10-012026-04-28
A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
Placebo, NPI-001 - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3RecruitingNacuity Pharmaceuticals, Inc.802026-10-012026-10-13
OCCUPATIONAL NOISE AND CHEMICAL EXPOSURE EFFECTS ON AUDITORY AND VESTIBULAR FUNCTION
Occupational Noise Exposure
Not yet recruitingOndokuz Mayıs University502026-09-032026-09-08
Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients.
Transfer of data of SONATA 2 cochlear implant recipients - Cochlear Implantation, Sensorineural Hearing Loss
Not yet recruitingMED-EL Elektromedizinische Geräte GesmbH2002026-09-012026-08-10
Optimizing Elderly Hearing Loss Care in Hong Kong A Cost-Effectiveness and Satisfactory Analysis of a Pilot Collaborative Model Between Otorhinolaryngologists and Family Medicine Specialists
Hearing Loss, Age-Related, Presbycusis
Not yet recruitingTseung Kwan O Hospital, Hong Kong5002026-09-012026-08-24
Clinical Evaluation of Hearing Aid OTC Self-Assessment Methods for Adults With Perceived Mild-to-Moderate Hearing Loss
OTC Hearing Aid Self Fitting App, Audiometry - Sensorineural Hearing Loss, Perceived Hearing Loss
Not applicableNot yet recruitingRehear Audiology Company LTD242026-08-152026-08-03
Auditory Intranerve Stimulation Perceptual Study
Auditory Nerve Implant (ANI) - Deafness, Perception
Not applicableRecruitingHannover Medical School52026-08-012026-08-27
Middle Ear Optical Coherence Tomography Imaging and Vibrometry in Patients With Hearing Loss
OCT - clear - Conductive Hearing Loss, Sensorineural Hearing Loss
Not yet recruitingAudioptics Medical Incorporated5002026-08-012026-07-29
Hidden Hearing Loss in Older Adults
Hidden Hearing Loss
RecruitingShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University2002026-06-152026-06-12
Comparative Efficacy of Earplug Usage Instruction
Video-Based Earplug Instruction, Paper-Based Earplug Instruction - Noise-Induced Hearing Loss, Hearing Protection Device Use
Not applicableEnrolling by invitationSirinthorn Chanaveroj642026-06-082026-07-28
A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
SPI-1005 200mg, SPI-1005 400mg, Placebo - Noise Induced Hearing Loss
Phase 2WithdrawnSound Pharmaceuticals, Incorporated2026-06-012026-06-03
Prediction of Age-Related Hearing Loss Based on Comprehensive Risk Factors
Not applicable- observational study - Age-related Hearing Loss
Not yet recruitingChinese PLA General Hospital10002026-06-012026-05-29

Showing 20 of 461. Sign in to see all of them.

Narrower conditions

Hearing Loss (114)  ·  Presbycusis (66)  ·  Hearing Loss, Noise-Induced (45)  ·  Usher Syndromes (33)  ·  Hearing Loss, Bilateral (32)  ·  Deafness (29)  ·  Retinitis Pigmentosa (26)  ·  Tinnitus (20)  ·  Hearing Loss, Sudden (17)  ·  Hearing Disorders (14)  ·  Cognitive Dysfunction (12)  ·  Hearing Loss, Hidden (9)  ·  Hearing Loss, Unilateral (9)  ·  Retinal Diseases (9)

Broader conditions

Pathological Conditions, Signs and Symptoms (461)  ·  Neurologic Manifestations (460)  ·  Nervous System Diseases (459)  ·  Sensation Disorders (459)  ·  Signs and Symptoms (459)  ·  Otorhinolaryngologic Diseases (456)  ·  Ear Diseases (454)  ·  Hearing Disorders (447)  ·  Hearing Loss (347)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (37)  ·  Congenital Abnormalities (35)  ·  Genetic Diseases, Inborn (34)  ·  Abnormalities, Multiple (33)  ·  Deaf-Blind Disorders (33)

Interventions

Hearing Aids (16)  ·  Cochlear Implants (14)  ·  Cochlear Implantation (9)  ·  Acetylcysteine (5)  ·  Hearing (4)  ·  Intravitreal Injections (4)  ·  Noise (4)  ·  Audiometry, Pure-Tone (3)  ·  Blood Specimen Collection (3)  ·  D-JNKI-1 (3)  ·  Dexamethasone (3)  ·  Surveys and Questionnaires (3)  ·  Valganciclovir (3)  ·  Vestibular Evoked Myogenic Potentials (3)  ·  Zonisamide (3)

Sponsors

Cochlear (29)  ·  MED-EL Elektromedizinische Geräte GesmbH (18)  ·  Sonova AG (18)  ·  Med-El Corporation (12)  ·  Oticon Medical (11)  ·  Advanced Bionics AG (9)  ·  Northwestern University (8)  ·  Frequency Therapeutics (6)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (6)  ·  Laboratoires Thea (5)  ·  VA Office of Research and Development (5)  ·  Washington University School of Medicine (5)  ·  Assiut University (4)  ·  Institut Pasteur (4)  ·  Johns Hopkins University (4)

Countries

United States (192)  ·  France (56)  ·  Germany (30)  ·  United Kingdom (30)  ·  Belgium (24)  ·  Canada (23)  ·  Australia (17)  ·  China (17)  ·  Switzerland (16)  ·  Netherlands (12)  ·  Denmark (10)  ·  Turkey (Türkiye) (9)  ·  Austria (7)  ·  Italy (6)  ·  Spain (6)

Top investigators

Carl LeBel, PhD (5)  ·  Yu-Hsiang Wu, PhD (4)  ·  Pamela Souza, PhD (3)  ·  Thomas B Friedman, Ph.D. (3)  ·  Arneborg Ernst, Prof. Dr. (2)  ·  Benoit Godey, Pr (2)  ·  Bettina Turnbull, Doctor of Audiology (2)  ·  Craig A Buchman, MD, FACS (2)  ·  David R Moore, Ph.D. (2)  ·  Eunyee Kwak, Ph.D. (2)  ·  Fred Telischi, MD (2)  ·  James Baumgartner, MD (2)  ·  Jinyu Qian, PhD (2)

Results publications

PMID 35386404, PMID 10547481, PMID 10590970, PMID 11893444, PMID 12851547, PMID 15064663, PMID 15341225, PMID 15715067, PMID 15978485, PMID 16640056, PMID 17069317, PMID 17204902, PMID 17453456, PMID 19086194, PMID 19253813, PMID 19275280, PMID 19450437, PMID 20202276, PMID 20329860, PMID 20562624, PMID 20588118, PMID 20635091, PMID 20665350, PMID 2069187, PMID 21117746, PMID 21117762, PMID 21233711, PMID 21340183, PMID 21568412, PMID 21921797, PMID 21974483, PMID 22122960, PMID 22750449, PMID 22773265, PMID 23275424, PMID 23280582, PMID 23341320, PMID 23396271, PMID 23411946, PMID 23862812, PMID 24024040, PMID 24467444, PMID 24506437, PMID 24705452, PMID 24708640, PMID 24755864, PMID 24975234, PMID 24999040, PMID 25029391, PMID 25133431

NIH funding

R01DC015997 (4), 2023 (2), R01DC012289 (2), 1UG1EY033293 (1), 2009 (1), 2017 (1), 2018 (1), I01RX001020 (1), I01RX005059 (1), K01DC018324 (1), K23AG065443 (1), K23DC016855 (1), K23DC022303 (1), P01AG009524 (1), R01DC001641 (1)